Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Debt / NOTE 4.500% 7/1
-
Market price (% of par)
-
111.63%
-
Total 13F principal
-
$53,214,000
-
Principal change
-
-$62,202,000
-
Total reported market value
-
$59,218,000
-
Number of holders
-
12
-
Value change
-
-$87,974,811
-
Number of buys
-
3
-
Number of sells
-
7
Institutional Holders of MERRIMACK PHARMACEUTICALS IN - NOTE 4.500% 7/1 as of Q2 2016
As of 30 Jun 2016 MERRIMACK PHARMACEUTICALS IN - NOTE 4.500% 7/1 had 12 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of $53,214,000 principal (par value or face value) of the bond of the company.
Largest 10 bondholders included LAZARD ASSET MANAGEMENT LLC, WOLVERINE ASSET MANAGEMENT LLC, JPMORGAN CHASE & CO, Polar Capital LLP, TANG CAPITAL MANAGEMENT LLC, PUTNAM INVESTMENTS LLC, AMERIPRISE FINANCIAL INC, Tekla Capital Management LLC, PALISADE CAPITAL MANAGEMENT LLC/NJ, and Polygon Management Ltd..
This table shows 12 bond principal holders of the security as of 30 Jun 2016.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.